Resident 81 was supposed to receive Avycaz, a costly IV antibiotic, but didn't get the first dose until October 25 at 2:00 p.m. The delay stemmed from the previous nursing director's failure to address pharmacy authorization requests in a timely manner, according to federal inspectors who investigated a complaint at the facility.
The problems began with a dosage mismatch. The infectious disease doctor had prescribed ceftazidime at 1.25 grams, but the pharmacy could only provide it in one-gram or two-gram doses. Avycaz was available in the correct 1.25-gram strength, but it was more expensive and required authorization.
LPN 477, who was working during the medication crisis, told inspectors she contacted the infectious disease doctor about the dosage problem. The doctor then ordered Avycaz at 1.25 grams instead. But getting the medication to the resident proved difficult.
"She reported daily to the DON and ADON about ceftazidime and Avycaz not being available," inspectors wrote about the LPN's attempts to resolve the situation. The nurse told investigators "it was a pattern with the previous DON and ADON to not address concerns the nurses had."
The facility had been notified before admission that Resident 81 would need IV antibiotics. Admission and Marketing staff member 445 confirmed during interviews that hospital case managers had communicated the resident's needs, including that "Avycaz was expensive and the facility would admit Resident 81."
Despite this advance warning, the authorization process stalled. The administrator confirmed to inspectors that "the pharmacy requested authorization to bill the facility for Avycaz, and the previous DON did not address the authorization in a timely manner resulting in missed doses of intravenous medication."
Pharmacy Technician 504 provided additional details about the medication confusion. The technician explained that ceftazidime wasn't available in the ordered 1.25-gram dose, but Avycaz was. However, the technician noted that "the delay of the ceftazidime and/or Avycaz could have been due to cost."
The current director of nursing, who wasn't in the position during October, reviewed the medical records for inspectors. She confirmed that Avycaz had been discussed before the resident's admission and verified that the admission order was initially for ceftazidime. When that medication didn't come in the correct dosage, Avycaz had to be ordered instead.
"The previous DON did not address the concerns with the correct dosage and approval for the medication to be sent to the facility for Resident 81 resulting in a treatment delay due to not receiving the ordered antibiotics timely," the current nursing director told inspectors.
LPN 477 disputed one detail from the pharmacy technician's account. The technician had suggested the nurse discontinued ceftazidime because the resident was already receiving Daptomycin, another antibiotic. But LPN 477 clarified she "did not discontinue the ceftazidime due to Resident 81 already receiving Daptomycin." Instead, she said the ceftazidime was discontinued after clarification from the infectious disease doctor, who then ordered Avycaz.
The resident's Medicare assessment showed they were cognitively intact and receiving antibiotics as part of their treatment plan. The inspection report doesn't specify what infection required the IV antibiotics or detail any clinical consequences from the delay.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents. The investigation was conducted in response to Complaint Number 2661530, suggesting someone reported the medication delays to authorities.
The case illustrates how administrative failures can create treatment gaps even when clinical staff recognize problems and attempt to resolve them. LPN 477's daily reports to nursing leadership went unaddressed, creating a pattern that ultimately delayed a resident's prescribed medical treatment.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Saint Luke Lutheran Home from 2025-11-24 including all violations, facility responses, and corrective action plans.